{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T08:07:49Z","timestamp":1748506069185,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:00:00Z","timestamp":1523577600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11255-018-1866-1","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T04:09:53Z","timestamp":1523592593000},"page":"1293-1300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"50","author":[{"given":"Melahat","family":"Coban","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7894-8913","authenticated-orcid":false,"given":"Ayca","family":"Inci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"1866_CR1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD et al (1992) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311\u20131319","journal-title":"Kidney Int"},{"key":"1866_CR2","first-page":"519","volume-title":"Schrier\u2019s diseases of the kidney","author":"S Somlo","year":"2012","unstructured":"Somlo S, Chapman AB (2012) Autosomal dominant polycystic kidney disease. In: Coffman TM, Falk RJ, Molitoris BA, Neilson EG, Schrier RW (eds) Schrier\u2019s diseases of the kidney, 9th edn. Lippincott Williams & Wilkins, Philadelphia, pp 519\u2013563","edition":"9"},{"key":"1866_CR3","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB et al (2006) CRISP investigators: volume progression in polycystic kidney disease. N Engl J Med 354:2122\u20132130","journal-title":"N Engl J Med"},{"key":"1866_CR4","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ et al (2003) Consortium for radiologic imaging studies of polycystic kidney disease cohort. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int 64:1035\u20131045","journal-title":"Kidney Int"},{"key":"1866_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2214\/ajr.145.2.229","volume":"145","author":"E Levine","year":"1985","unstructured":"Levine E, Cook LT, Grantham JJ (1985) Liver cysts in autosomal-dominant polycystic kidney disease: clinical and computed tomographic study. Am J Roentgenol 145:229\u2013233","journal-title":"Am J Roentgenol"},{"key":"1866_CR6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1053\/j.ajkd.2005.08.026","volume":"46","author":"WC O\u2019Neill","year":"2005","unstructured":"O\u2019Neill WC, Robbin ML, Bae KT et al (2005) Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the consortium of renal imaging studies in polycystic kidney disease (CRISP). Am J Kidney Dis 46:1058\u20131064","journal-title":"Am J Kidney Dis"},{"key":"1866_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s005860050076","volume":"7","author":"KM Diab","year":"1998","unstructured":"Diab KM, Ollmar S, Sevastik JA, Willers U, Svensson A (1998) Volumetric determination of normal and scoliotic vertebral bodies. Eur Spine J 7:282\u2013288","journal-title":"Eur Spine J"},{"key":"1866_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321\u2013337","journal-title":"Annu Rev Med"},{"key":"1866_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Chapman AB, Torres VE (2006) Volume progression in autosomal dominant polycystic kidney disease: the maj\u00f6r factor determining clinical outcomes. Clin J Am Soc Nephrol 1:148\u2013157","journal-title":"Clin J Am Soc Nephrol"},{"key":"1866_CR10","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1126\/science.284.5422.1994","volume":"284","author":"J Holash","year":"1999","unstructured":"Holash J, Maisonpierre PC, Compton D et al (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994\u20131998","journal-title":"Science"},{"key":"1866_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/hep.1840400413","volume":"40","author":"MT Nichols","year":"2004","unstructured":"Nichols MT, Gidey E, Matzakos T et al (2004) Secretion of cytokines and growth factors into ADPKD liver cyst fluid. Hepatology 40:836\u2013846","journal-title":"Hepatology"},{"key":"1866_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","volume":"60","author":"E Bello-Reuss","year":"2001","unstructured":"Bello-Reuss E, Holubec K, Rajaraman S (2001) Angiogenesis in autosomal-dominant polycystic kidney disease. Kidney Int 60:37\u201345","journal-title":"Kidney Int"},{"key":"1866_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/sj.ki.5001725","volume":"70","author":"W Wei","year":"2006","unstructured":"Wei W, Popov V, Walocha JA, Wen J, Bello-Reuss E (2006) Evidence of angiogenesis and microvascular regression in autosomal-dominant polycystic kidney disease kidneys: a corrosion cast study. Kidney Int 70:1261\u20131268","journal-title":"Kidney Int"},{"key":"1866_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) CKD-EPI (chronic kidney disease epidemiology collaboration): a new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"1866_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.ajkd.2015.01.030","volume":"66","author":"A Alam","year":"2015","unstructured":"Alam A, Dahl NK, Lipschutz JH et al (2015) Total kidney volume in autosomal dominant polycystic kidney disease: a biomarker of disease progression and therapeutic efficacy. Am J Kidney Dis 66:564\u2013576","journal-title":"Am J Kidney Dis"},{"key":"1866_CR16","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2215\/CJN.02810608","volume":"4","author":"MA Cadnapaphornchai","year":"2009","unstructured":"Cadnapaphornchai MA, McFann K, Strain JD, Masoumi A, Schrier RW (2009) Prospective change in renal volume and function in children with ADPKD. Clin J Am Soc Nephrol 4:820\u2013829","journal-title":"Clin J Am Soc Nephrol"},{"key":"1866_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1148\/radiology.211.3.r99jn19623","volume":"211","author":"J Bakker","year":"1999","unstructured":"Bakker J, Olree M, Kaatee R et al (1999) Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Radiology 211:623\u2013628","journal-title":"Radiology"},{"key":"1866_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"EC Gall","year":"2013","unstructured":"Gall EC, Audr\u00e9zet M, Chen J et al (2013) Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24:1006\u20131013","journal-title":"J Am Soc Nephrol"},{"key":"1866_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.ki.5002624","volume":"73","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ, Cook LT, Torres VE et al (2008) Determinants of renal volume in autoso-mal dominant polycystic kidney disease. Kidney Int 73:108\u2013116","journal-title":"Kidney Int"},{"key":"1866_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1101\/gad.13.9.1055","volume":"13","author":"NW Gale","year":"1999","unstructured":"Gale NW, Yancopoulos GD (1999) Growth factors acting via endothelial cell specific receptor tyrosine kinases: VEGFs, angiopoietins, and ehrins in vascular development. Genes Dev 13:1055\u20131066","journal-title":"Genes Dev"},{"key":"1866_CR21","first-page":"374","volume":"71","author":"A Minchenko","year":"1994","unstructured":"Minchenko A, Bauer T, Salceda S, Caro L (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vivo and in vitro. Lab Invest 71:374\u2013379","journal-title":"Lab Invest"},{"key":"1866_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/BF03401566","volume":"1","author":"DT Shima","year":"1995","unstructured":"Shima DT, Adamis AP, Ferrara N et al (1995) Hypoxic induction of endothelial cell growth factors in retinal cells. Mol Med 1:182\u2013193","journal-title":"Mol Med"},{"key":"1866_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1053\/j.ajkd.2007.04.025","volume":"50","author":"H Izzedine","year":"2007","unstructured":"Izzedine H, Rixe O, Billemont B, Baumelou A, Deray G (2007) Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension. Am J Kidney Dis 50:203\u2013218","journal-title":"Am J Kidney Dis"},{"key":"1866_CR24","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5002550","volume":"72","author":"Y Tao","year":"2007","unstructured":"Tao Y, Kim J, Yin Y et al (2007) VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int 72:1358\u20131366","journal-title":"Kidney Int"},{"key":"1866_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00041552-200301000-00008","volume":"12","author":"D-H Kang","year":"2003","unstructured":"Kang D-H, Johnson RJ (2003) Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 12:43\u201349","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1866_CR26","doi-asserted-by":"publisher","first-page":"C419","DOI":"10.1152\/ajpcell.00038.2007","volume":"293","author":"CR Amura","year":"2007","unstructured":"Amura CR, Brodsky KS, Groff R, Gattone VH, Voelkel NF, Doctor RB (2007) VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25\/-) mice. Am J Physiol Cell Physiol 293:C419\u2013C428","journal-title":"Am J Physiol Cell Physiol"},{"key":"1866_CR27","doi-asserted-by":"publisher","first-page":"F773","DOI":"10.1152\/ajprenal.00058.2011","volume":"301","author":"S Raina","year":"2011","unstructured":"Raina S, Honer M, Kr\u00e4mer SD et al (2011) Anti-VEGF antibody treatment accelerates polycystic kidney disease. Am J Physiol Renal Physiol 301:F773\u2013F783","journal-title":"Am J Physiol Renal Physiol"},{"key":"1866_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1172\/JCI6740","volume":"104","author":"T Ostendorf","year":"1999","unstructured":"Ostendorf T, Kunter U, Loos A, Eitner F, Regele H, Kerjaschki D et al (1999) VEGF165 mediates glomerular endothelial repair. J Clin Invest 104:913\u2013923","journal-title":"J Clin Invest"},{"key":"1866_CR29","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/ndt\/gfq060","volume":"25","author":"S David","year":"2010","unstructured":"David S, K\u00fcmpers P, Lukasz A et al (2010) Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant 25:2571\u20132576","journal-title":"Nephrol Dial Transplant"},{"key":"1866_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/ki.2010.355","volume":"79","author":"BY Reed","year":"2011","unstructured":"Reed BY, Masoumi A, Elhassan E et al (2011) Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease. Kidney Int 79:128\u2013134","journal-title":"Kidney Int"},{"key":"1866_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.11.004","volume":"180","author":"HS Lim","year":"2005","unstructured":"Lim HS, Lip GYH, Blann AD (2005) Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage\/dysfunction and atherosclerosis. Atherosclerosis 180:113\u2013118","journal-title":"Atherosclerosis"},{"key":"1866_CR32","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/ndt\/gfq832","volume":"26","author":"G Mayer","year":"2011","unstructured":"Mayer G (2011) Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease. Nephrol Dial Transplant 26:1132\u20131137","journal-title":"Nephrol Dial Transplant"},{"key":"1866_CR33","first-page":"93","volume":"38","author":"YB Yang","year":"2007","unstructured":"Yang YB, Liu F, Huang SM (2007) The expression and significance of the angiopoietin-1 in the kidney of diabetic rats. Sichuan Da Xue Xue Bao Yi Xue Ban 38:93\u201396","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"1866_CR34","doi-asserted-by":"publisher","first-page":"e54668","DOI":"10.1371\/journal.pone.0054668","volume":"8","author":"FC Chang","year":"2013","unstructured":"Chang FC, Lai TS, Chiang CK et al (2013) Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. PLoS ONE 8:e54668","journal-title":"PLoS ONE"},{"key":"1866_CR35","first-page":"10","volume":"9","author":"P Brenchley","year":"1996","unstructured":"Brenchley P (1996) VEGF\/VPF: a modulator of microvascular function with potential roles in glomerular pathophysiology. J Nephrol 9:10\u201317","journal-title":"J Nephrol"},{"key":"1866_CR36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1046\/j.1523-1755.1999.0550031063.x","volume":"55","author":"NJA Webb","year":"1999","unstructured":"Webb NJA, Watson CJ, Roberts ISD et al (1999) Circulating VEGF is not increased during relapses of steroid-sensitive nephrotic syndrome. Kidney Int 55:1063\u20131071","journal-title":"Kidney Int"},{"key":"1866_CR37","first-page":"303","volume":"31","author":"DB Jones","year":"1974","unstructured":"Jones DB (1974) Arterial and glomerular lesions associated with severe hypertension. Light and electron microscobic studies. Lab Invest 31:303\u2013313","journal-title":"Lab Invest"},{"key":"1866_CR38","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/ki.1992.413","volume":"42","author":"M Zeier","year":"1992","unstructured":"Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E (1992) Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int 42:1259\u20131265","journal-title":"Kidney Int"},{"key":"1866_CR39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1681\/ASN.V75661","volume":"7","author":"K Shulman","year":"1996","unstructured":"Shulman K, Rosen S, Tognazzi K, Manseau E, Brown A (1996) Expression of vascular permeability factor is altered in many glomerular diseases. J Am Soc Nephrol 7:661\u2013666","journal-title":"J Am Soc Nephrol"},{"key":"1866_CR40","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-012-2305-7","volume":"28","author":"JL Huang","year":"2013","unstructured":"Huang JL, Woolf AS, Long DA (2013) Angiogenesis and autosomal dominant polycystic kidney disease. Pediatr Nephrol 28:1749\u20131755","journal-title":"Pediatr Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1866-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1866-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T12:26:19Z","timestamp":1660911979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1866-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1866"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1866-1","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2018,4,13]]},"assertion":[{"value":"10 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}